本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ocular Therapeutix

7.31
+0.14001.95%
盘后7.310.00000.00%19:57 EDT
成交量:163.32万
成交额:1,184.62万
市值:11.62亿
市盈率:-5.98
高:7.38
开:7.16
低:7.12
收:7.17
数据加载中...
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

重要事件披露

Form 8-K - Current report
2025/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities